The PARAGON Heart Failure trial – ongoing investigation of the angiotensin receptor antagonist/neprilysin inhibitor sacubitril/valsartan in heart failure patients with hypertension and preserved ejection fraction

• Sverre E. Kjeldsen,
• Krzysztof Narkiewicz,
• Michel Burnier,
• Suzanne Oparil

Affiliations

Sverre E. Kjeldsen

University of Oslo

Krzysztof Narkiewicz

Medical University of Gdansk

Michel Burnier

Centre Hospitalier Universitaire Vaudois

Suzanne Oparil

University of Alabama at Birmingham